pharma · Hypovolemia · Pruritus, Chronic Kidney Diseases
Fresenius Kabi Australia
Fresenius Kabi Australia Pty Limited
Fresenius Kabi Australia is a pharma organization headquartered in Mount Kuring-Gai, AU. Primary therapeutic focus areas include Hypovolemia, Pruritus, Chronic Kidney Diseases, Chronic inflammatory diseases. NovaPharmaNe
Mount Kuring-Gai, AU HQ
150 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Mount Kuring-Gai, AU
- Employees
- 150
- Programs
- 5
- Drugs
- 6
- Patents
- 0
Comparison of Prefilled syringe and Autoinjector presentations of FYB202
Phase 1 · other · Chronic inflammatory diseases
Comparison of Prefilled syringe and Autoinjector presentations of FYB202 for Chronic inflammatory diseases is a Phase 1 program (other) at Fresenius Kabi Australia Pty Limited with 1 ClinicalTrials.gov record(s).
Internal code FYB202-004
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Fresenius Kabi Australia Pty Limited
- Phase
- Phase 1
- Modality
- other
- Indication
- Chronic inflammatory diseases
- Status
- active
- Trials
- 1